These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
225 related articles for article (PubMed ID: 9528936)
1. Chronic treatment with estrogen up-regulates expression of sst2 messenger ribonucleic acid (mRNA) but down-regulates expression of sst5 mRNA in rat pituitaries. Kimura N; Tomizawa S; Arai KN; Kimura N Endocrinology; 1998 Apr; 139(4):1573-80. PubMed ID: 9528936 [TBL] [Abstract][Full Text] [Related]
2. Effect of 17beta-estradiol on somatostatin receptor expression and inhibitory effects on growth hormone and prolactin release in rat pituitary cell cultures. Djordjijevic D; Zhang J; Priam M; Viollet C; Gourdji D; Kordon C; Epelbaum J Endocrinology; 1998 May; 139(5):2272-7. PubMed ID: 9564833 [TBL] [Abstract][Full Text] [Related]
3. Modulation of pituitary somatostatin receptor subtype (sst1-5) messenger ribonucleic acid levels by changes in the growth hormone axis. Park S; Kamegai J; Johnson TA; Frohman LA; Kineman RD Endocrinology; 2000 Oct; 141(10):3556-63. PubMed ID: 11014208 [TBL] [Abstract][Full Text] [Related]
4. Pituitary somatostatin receptor (sst)1-5 expression during rat development: age-dependent expression of sst2. Reed DK; Korytko AI; Hipkin RW; Wehrenberg WB; Schonbrunn A; Cuttler L Endocrinology; 1999 Oct; 140(10):4739-44. PubMed ID: 10499533 [TBL] [Abstract][Full Text] [Related]
5. Homologous and heterologous in vitro regulation of pig pituitary somatostatin receptor subtypes, sst1, sst2 and sst5 mRNA. Luque RM; Park S; Peng XD; Delgado E; Gracia-Navarro F; Kineman RD; Malagón MM; Castaño JP J Mol Endocrinol; 2004 Apr; 32(2):437-48. PubMed ID: 15072550 [TBL] [Abstract][Full Text] [Related]
6. Estrogen regulates somatostatin receptor subtype 2 messenger ribonucleic acid expression in human breast cancer cells. Xu Y; Song J; Berelowitz M; Bruno JF Endocrinology; 1996 Dec; 137(12):5634-40. PubMed ID: 8940394 [TBL] [Abstract][Full Text] [Related]
7. Role of glucocorticoids in the regulation of pituitary somatostatin receptor subtype (sst1-sst5) mRNA levels: evidence for direct and somatostatin-mediated effects. Park S; Kamegai J; Kineman RD Neuroendocrinology; 2003 Sep; 78(3):163-75. PubMed ID: 14512709 [TBL] [Abstract][Full Text] [Related]
8. 17-beta-estradiol-dependent regulation of somatostatin receptor subtype expression in the 7315b prolactin secreting rat pituitary tumor in vitro and in vivo. Visser-Wisselaar HA; Van Uffelen CJ; Van Koetsveld PM; Lichtenauer-Kaligis EG; Waaijers AM; Uitterlinden P; Mooy DM; Lamberts SW; Hofland LJ Endocrinology; 1997 Mar; 138(3):1180-9. PubMed ID: 9048625 [TBL] [Abstract][Full Text] [Related]
9. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. Bertherat J; Tenenbaum F; Perlemoine K; Videau C; Alberini JL; Richard B; Dousset B; Bertagna X; Epelbaum J J Clin Endocrinol Metab; 2003 Nov; 88(11):5353-60. PubMed ID: 14602773 [TBL] [Abstract][Full Text] [Related]
10. Expression and localisation of somatostatin receptor subtypes sst1-sst5 in areas of the rat medulla oblongata involved in autonomic regulation. Spary EJ; Maqbool A; Batten TF J Chem Neuroanat; 2008 Jan; 35(1):49-66. PubMed ID: 17646081 [TBL] [Abstract][Full Text] [Related]
11. Estradiol reduces pituitary responsiveness to somatostatin (SRIF-14) and down-regulates the expression of somatostatin sst2 receptors in female goldfish pituitary. Cardenas R; Lin X; Canosa LF; Luna M; Arámburo C; Peter RE Gen Comp Endocrinol; 2003 Jun; 132(1):119-24. PubMed ID: 12765651 [TBL] [Abstract][Full Text] [Related]
12. Dopamine receptor subtype 2 and somatostatin receptor subtype 5 expression influences somatostatin analogs effects on human somatotroph pituitary adenomas in vitro. Zatelli MC; Piccin D; Tagliati F; Bottoni A; Ambrosio MR; Margutti A; Scanarini M; Bondanelli M; Culler MD; degli Uberti EC J Mol Endocrinol; 2005 Oct; 35(2):333-41. PubMed ID: 16216913 [TBL] [Abstract][Full Text] [Related]
13. Distribution and characterisation of somatostatin receptor mRNA and binding sites in the brain and periphery. Fehlmann D; Langenegger D; Schuepbach E; Siehler S; Feuerbach D; Hoyer D J Physiol Paris; 2000; 94(3-4):265-81. PubMed ID: 11088004 [TBL] [Abstract][Full Text] [Related]
14. Somatostatin (SRIF) receptor subtype 2 and 5 gene expression in growth hormone-secreting pituitary adenomas: the relationship with endogenous srif activity and response to octreotide. Park C; Yang I; Woo J; Kim S; Kim J; Kim Y; Sohn S; Kim E; Lee M; Park H; Jung J; Park S Endocr J; 2004 Apr; 51(2):227-36. PubMed ID: 15118275 [TBL] [Abstract][Full Text] [Related]
15. Cell specific expression of the sst2A and sst5 somatostatin receptors in the rat anterior pituitary. Mezey E; Hunyady B; Mitra S; Hayes E; Liu Q; Schaeffer J; Schonbrunn A Endocrinology; 1998 Jan; 139(1):414-9. PubMed ID: 9421441 [TBL] [Abstract][Full Text] [Related]
16. Preferential expression of sst2A over sst2B somatostatin receptor splice variant in rat brain and pituitary. Sarret P; Botto JM; Vincent JP; Mazella J; Beaudet A Neuroendocrinology; 1998 Jul; 68(1):37-43. PubMed ID: 9695937 [TBL] [Abstract][Full Text] [Related]